Abstract
Syntheses based on podophyllotoxin have led to the inclusion among antitumoral agents valuable in practice of the preparations etoposide(I) and teniposide(II). These compounds are, respectively, the 4,6-ethylidene and 4,6-thenylidene derivatives of 4′-dimethylepipodophyllotoxin β-D-glucopyranoside. A review has been made of methods of synthesizing (I) and (II) and for their experimental investigation. Some conclusions are given from the results of clinical trials. Although (I) and (II) have been accepted for practical use, their clinical activity is limited. The principles of the experimental selection of antitumoral agents are considered particularly. Considerations are expressed concerning the possibilities of improving the results of the search for antitumoral agents of plant origin.
Similar content being viewed by others
Literature cited
N. N. Blokhin and N. I. Perebodchikova, The Chemotherapy of Tumoral Diseases [in Russian], Moscow (1984).
G. V. Krugova, in: The Chemotherapy of Tumoral Diseases (ed. N. N. Blokhin and N. I. Perebodchikova) [in Russian], Moscow (1984), p. 238.
M. D. Mashkovskii, Drugs [in Russian], Moscow, Part 2 (1984).
H. Emmenegger, H. Stählein, et al., Arzneim.-Forsch.,11, 327 (1961).
J. L. Hartwell and A.W. Schrecker, Fortschr. Chem. Org. Naturst.,15, 83 (1958).
I. Jardin, in: Medicinal Chemistry, Vol. 16, Anti-Cancer Agents Based on Natural Product Models (ed. J. M. Cassady and J. D. Dourous), Academic Press New York (1980), p. 318.
V. Podvysotskii, Farmatsevtich. Zh.,3, 49 (1881); Abstract in Ber.,15, 377 (1882).
M. G. Kelly and J. L. Hartwell, J. Natl. Cancer Inst.,14, 967 (1954).
V. Seidlova-Masinova, J. Malinský, and F. Santavý, J. Natl. Cancer Inst.,18, 359 (1957).
I. Weber and H. Schildt, Med. Monatsheft.,19, 10 (1965).
A. M. Arnold and J. M. A. Whitehouse, Lancet, No. 8252, 912 (1981).
A. W. Schrecker, P. B. Maury, J. L. Hartwell, and J. Leiter, J. Am. Chem. Soc.,77, 6565 (1955).
A. Stoll, J. Renz, and A. Wartburg, Helv. Chim. Acta,37, 1747 (1954).
J. Leiter, V. Downing, J. L. Hartwell, and M. J. Shear, J. Natl. Cancer Inst.,10, 1273 (1950).
A. Stoll, J. Rutschmann, A. Wartburg, and J. Renz. Helv. Chim. Acta,39, 993 (1956).
A. Wartburg, E. Angeliker, and J. Renz, Helv. Chim. Acta,40, 1331 (1957).
M. Kuhn and W. Wartberg, Helv. Chim. Acta,46, 2147 (1963).
A. Wartburg, M. Kuhn, and H. Licht, Helv. Chim. Acta,47, 1203 (1964).
H. Emmenegger, H. Stähelin, J. Rutschmann, J. Renz, and A. Wartburg, Arzneim.-Forsch.,11, 459 (1961).
J. Rutschmann and J. Renz, Helv. Chim. Acta,42, 890 (1959).
H. Stählein and A. Cerletti, Schweiz, Med. Wochenschr.,94, 1490 (1964).
M. Soldati and A. Fioretti, Tumori,50, 101 (1964).
H. Stählein, in: Experimentelle und klinische Erfahrungen mit Podophyllinderivaten in der Tumortherapid (eds. H. Lettré and S. Witte), F. K. Schattauer Verlag, Stuttgart (1967), p. 19.
H. Léttre and W. Witte, Experimentelle und klinische Erfahrungen mit podophyllinederivaten in der Tumortherapie, F. K. Schattauer Verlag, Stuttgart (1967).
C. Keller-Juslin, M. Kuhn, A. Wartburg, and H. Stähelin, J. Med. Chem.,14, 936 (1971).
H. M. Rauen and K. Narporth, Arzneim.-Forsch.,16, 1524 (1966).
D. M. Golderberg and E. Ammersdörfer, Arzneim.-Forsch.,20, 789 (1970).
J. K. Kelleher, Mol. Pharmacol.,13, 232 (1977).
R. C. Chakravorty, S. K. Sarker, et al., Br. J. Cancer,21, 33 (1967).
O. Stamm, Münch. Med. Wochenschr,106, 41 (1964).
V. K. Vaitkevicius and M. L. Red, Cancer Chemother. Rep.,50, 565 (1966).
M. Rozencweig, D. D. Von Hoff, et al., Cancer,40, 334 (1977).
M. Kuhn and A. Wartburg, Helv. Chim. Acta,51, 163 (1968).
W. Koenigs and E. Knorr, Berichte,34, 957 (1901).
M. Kuhn and A. Wartburg, Experientia,19, 391 (1963).
J. Renz, M. Kuhn, and A. Wartburg, Ann. Chem.,681, 207 (1965); M. Kuhn and A. Wartburg, Helv. Chim. Acta,51, 1631 (1968).
A. Stoll. A. Wartburg, E. Angliker, and J. Renz. J. Am. Chem. Soc.,76, 5004 (1954).
M. Kuhn, C. Keller-Juslen, and A. Wartburg, Helv. Chim. Acta,52, 944 (1969).
M. Kuhn and A. Wartburg, Helv. Chim. Acta,52, 948 (1969).
A. G. Pederson and H. H. Hansen, Carcer Treat. Rev.,10, 245 (1983).
F. Valeriote and H. Grotes, J. Natl. Cancer Inst.,76, 61 (1986).
J. D. Loike, Cancer Chemoth. Pharmacol.,7, 103 (1982).
H. Stähelin, Europ. J. Cancer,6, 303 (1970).
H. Stähelin, Europ. J. Cancer,9, 215 (1973).
J. D. Loike and S. B. Horowitz, Biochemistry,15, 5443 (1976).
J. D. Loike and S. B. Horowitz, Biochemistry,15, 5435 (1976).
W. D. MacRoe and G. H. Towers, Phytochemistry,22, 1207 (1984).
R. A. Bender, in: Cancer Chemoth., ed. H. M. Pinedo (1979), p. 93.
H. Stählein, Planta Med.,22, 336 (1972).
B. F. Issel, Cancer Chemother. Pharmacol.,7, 73 (1982).
W. F. Jungi and M. J. Senn, Cancer. Treat. Rep.,59, 737 (1975).
A. Catton, C. Poury, et al., Eur. J. Cancer,12, 797 (1976).
R. D. Tucker, A. Fergusson, et al., Cancer,41, 1710 (1976).
F. Cavelli, R. W. Sonntag, et al., Cancer Treat. Rep.,62, 473 (1978).
S. Begun, I. Ullah, and B. C. Nunning, FRG Patent No. 3,509,741 (C1. A61K31/00); Chem. Abstr.,103, 220834 (1985).
R. E. Bellet, R. B. Catulano, et al., Cancer Treat. Rep.,62, 445 (1978).
P. A. Radice, P. A. Bunn, and D. C. Ihde, Cancer Treat. Rep.,63, 1231 (1979).
M. K. Spigelman, R. A. Zappula, J. F. Holland, et al., J. Neurosurg.,61, 674 (1984).
R. P. Abratt, W. Levin, et al., Cancer Treat. Rep.,69, 235 (1985).
B. F. Issell, L. H. Einhorn, et al., Cancer Treat. Rep.,69, 127 (1985).
T. A. Hages, M. Abramowitch, and A. A. Green, Cancer Treat. Rep.,69, 439 (1985).
M. Markman, M. D. Abeloff, et al., Cancer Treat. Rep.69, 161 (1985); A. B. Gasser, W. P. Steward, et al., Cancer Treat. Rep.69, 225 (1985); J. A. Lopez, J. Mann, et al., Cancer Treat. Rep.,69, 369 (1985).
M. J. Peckman, A. Horwik, et al., Cancer Treat. Rep.,69, 483 (1985); M. Bertrand, P. Multhauf, et al., Cancer Treat. Rep.69, 1335 (1985); S. D. Williams, L. H. Einhorn, et al., Cancer,46, 2154 (1980).
S. R. Helms, D. J. Oblon, et al., Cancer Treat. Rep.,69, 783 (1985); D. K. Kalwinsky, G. R. Dahl, et al., Cancer Treat. Rep.,69, 887 (1985); I. R. Jodson, E. Wiltshow, Cancer Chemother. Pharm.,14, 258 (1985).
D. Cunningham, S. V. Banham, et al., Cancer Chemother. Pharm.,15, 303 (1985).
J. Estape et al., Cancer Chemother. Pharm.,10, 154 (1983).
P. Bonomi, W. O. Raily, et al., Cancer Treat. Rep.,69, 1007 (1985); D. K. Budman, J. Anderson, et al., Cancer Treat. Rep.,69, 719 (1985).
L. L. Porter, D. H. Johnson, et al., Cancer Treat. Rep.,69, 479 (1985).
V. V. Kiselev, Advances in Medicine and Medical Technique [in Russian], Vses. NIIMed. Med. Tekh. Inf., No. 11 (1983), p. 60.
M. J. Staquet, D. P. Byar, et al., Cancer Treat. Rep.,69, 753 (1983).
J. M. Venditti, Cancer Treat. Rep.,67, 767 (1983).
H. E. Skipper, Cancer Treat. Rep.,70, 3 (1986).
V. G. Pashinskii and K. V. Yaremenko, Problems of Oncological Pharmacotherapy [in Russian], Tomsk (1983).
A. Goldin, A. A. Serpik, and N. Mantel, Cancer Chemother. Pharm.,50, 173 (1966).
Z. P. Sof'ina, The Chemotherapy of Tumoral Diseases [in Russian], Moscow (1984), p. 11.
A. Goldin and J. M. Venditti, Recent Results in Cancer Research,70, 5 (1980).
E. Frei, Science,217, 600 (1982).
J. S. Driscoll. Cancer Treat. Rep.,68, 63 (1984).
J. E. Talmadge and R. B. Herberman, Cancer Treat. Rep.,68, 171 (1984).
A. W. Hamburger, J. Nat. Cancer Inst.,66, 981 (1980).
R. H. Shoemaker, M. K. Walpert, et al., Cancer Res.,45, 2145 (1985).
S. E. Salman, Cancer Treat. Rep.,68, 117 (1984); M. Rozencweig, C. Sanders, et al., Eur. J. Cancer Clin. Oncol.,21, 195 (1985).
Ya. V. Dobrynin, Éksp. Onkol.,7, No. 2, 9 (1985); S. A. Potapov and D. B. Korman, Éksp. Oncol.,8, No. 1, 7 (1986).
R. A. Hickie, J.-M. Wet, et al., Can. J. Biochem. Cell Biol.,61, 934 (1983).
F. C. Stevens, Can. J. Biochem. Cell Biol.,61, 906 (1983).
Additional information
All-Union Oncological Scientific Center of the USSR Academy of Medical Sciences, Moscow. Translated from Khimiya Prirodnykh Soedinenii, No. 5, pp. 638–652, September–October, 1987.
Rights and permissions
About this article
Cite this article
Kiselev, V.V. Synthesis of antitumoral agents from podophyllotoxin. Chem Nat Compd 23, 529–540 (1987). https://doi.org/10.1007/BF00598666
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00598666